{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T17:43:42Z","timestamp":1648835022573},"reference-count":39,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2021,5,31]]},"DOI":"10.7883\/yoken.jjid.2020.504","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T22:06:39Z","timestamp":1604009199000},"page":"209-213","source":"Crossref","is-referenced-by-count":0,"title":["Availability of &lt;i&gt;Chlamydia trachomatis&lt;\/i&gt; Testing and Its Importance in the Surveillance of Genital Chlamydial Infection"],"prefix":"10.7883","volume":"74","author":[{"given":"Xinlong","family":"Chen","sequence":"first","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, China"},{"name":"Shandong Provincial Hospital for Skin Diseases and Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University and Shandong Academy of Medical Sciences, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Gan","sequence":"additional","affiliation":[{"name":"Shandong Provincial Hospital for Skin Diseases and Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University and Shandong Academy of Medical Sciences, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Degui","family":"Chang","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiongfei","family":"Mi","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianchang","family":"Liu","sequence":"additional","affiliation":[{"name":"Shandong Provincial Hospital for Skin Diseases and Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University and Shandong Academy of Medical Sciences, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Davies B, Turner KME, Frolund M. Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. Lancet Infect Dis. 2016; 16:1057-64.","DOI":"10.1016\/S1473-3099(16)30092-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Adachi K, Nielsen-Saines K, Klausner JD, et al. <i>Chlamydia trachomatis<\/i> infection in pregnancy: the global challenge of preventing adverse pregnancy and infant outcomes in Sub-Saharan Africa and Asia. Biomed Res Int. 2016; 9315757.","DOI":"10.1155\/2016\/9315757"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ahmad SF, Brown JK, Campbell LL, et al. Pelvic chlamydial infection predisposes to ectopic pregnancy by upregulating integrin beta1 to promote embryo-tubal attachment. EBioMedicine. 2018; 29: 159-65.","DOI":"10.1016\/j.ebiom.2018.02.020"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shannon R Galvin, Myron S Cohen. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol. 2004, 2:33.","DOI":"10.1038\/nrmicro794"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bernstein KT, Marcus JL, Nieri G, et al. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J. Acquir. Immune Defc. Syndr. 2010; 53: 537-43.","DOI":"10.1097\/QAI.0b013e3181c3ef29"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis. 2009; 9:118-29.","DOI":"10.1016\/S1473-3099(09)70021-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lima LM, Hoelzle CR, Sim\u00f5es RT, et al. Sexually transmitted infections detected by multiplex real time PCR in asymptomatic women and association with cervical intraepithelial neoplasia. Rev Bras Ginecol Obstet. 2018; 40:540-6.","DOI":"10.1055\/s-0038-1669994"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Das, Manjulika. Chlamydia infection and ovarian cancer risk. Lancet Oncol. 2018; 19: e338.","DOI":"10.1016\/S1470-2045(18)30421-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Low N, Redmond S, Uuskula A, et al. Screening for genital chlamydia infection. Cochrane Database Syst Rev. 2016; 9: CD010866.","DOI":"10.1002\/14651858.CD010866.pub2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kamwendo F, Forslin L, Bodin L, et al. Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease: a 25-year study from an urban area of central Sweden. Sex Transm Dis. 1996; 23: 384-91.","DOI":"10.1097\/00007435-199609000-00007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Rours GIJG, Smith-Norowitz TA, Ditkowsky J, et al. Cost-effectiveness analysis of <i>Chlamydia trachomatis<\/i> screening in Dutch pregnant women. Path Global Health. 2016; 110: 292-302.","DOI":"10.1080\/20477724.2016.1258162"},{"key":"12","unstructured":"12. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015; 64:1-137."},{"key":"13","unstructured":"13. Public Health Agency of Canada. Canadian guidelines on sexually transmitted infections 2017. Available at &lt;https:\/\/www.canada.ca\/en\/public-health\/services\/infectious-diseases\/sexual-health-sexually-transmitted-infections\/canadian-guidelines\/sexually-transmittedinfections.html&gt;. Accessed May 10 2021."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Newman L, Rowley J, Vander Hoorn S, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015; 10: e0143304.","DOI":"10.1371\/journal.pone.0143304"},{"key":"15","unstructured":"15. Chlamydia control in Europe: literature review.European Centre for Disease Prevention and Control (2014). Available at &lt;https:\/\/ www.mendeley.com\/catalogue\/ff79993b-fa7a-3355-b70e-e757e9c4af06\/&gt;. Accessed May 10 2021."},{"key":"16","unstructured":"16. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2013. Atlanta, GA: US Department of Health and Human Services. Available at &lt;https:\/\/www.cdc.gov\/std\/stats\/&gt;. Accessed May 10 2021."},{"key":"17","unstructured":"17. European Centre for Disease Prevention and Control. Surveillance report, Annual epidemiological report for 2016--Chlamydia infection. Available at &lt;https:\/\/www.ecdc.europa.eu\/en\/publications-data&gt;. Accessed May 10 2021."},{"key":"18","unstructured":"18. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2016. Atlanta: U.S. Department of Health and Human Services. 2017. &lt;https:\/\/www.cdc.gov\/std\/stats&gt;. Accessed May 10 2021."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Badrakh Jugderjav, Zayasaikhan Setsen, Jagdagsuren Davaalkham, et al. Trends in adult chlamydia and gonorrhoea prevalence, incidence and urethral discharge case reporting in Mongolia from 1995 to 2016 - estimates using the Spectrum-STI model. Western Pac Surveill Response J. 2017; 8: 20-9.","DOI":"10.5365\/wpsar.2017.8.2.007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kularatne RS, Niit R, Rowley J, et al. Adult gonorrhea, chlamydia and syphilis prevalence, incidence, treatment and syndromic case reporting in South Africa: Estimates using the Spectrum-STI model, 1990-2017. PLoS One. 2018; 13: e0205863.","DOI":"10.1371\/journal.pone.0205863"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lopez-de-Munain J, Camara-Perez MD, Imaz-Perez M, et al. <i>Chlamydia trachomatis<\/i> re-infection in Spain: A STI clinic-based cohort study. Enferm Infecc Microbiol Clin. 2017; 35: 165-73.","DOI":"10.1016\/j.eimce.2017.02.010"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ji Y, Ma XX, Li Z, et al. The burden of human papillomavirus and <i>Chlamydia trachomatis<\/i> coinfection in women: a large cohort study in Inner Mongolia, China. J Infect Dis. 2019; 219: 206-14.","DOI":"10.1093\/infdis\/jiy497"},{"key":"23","unstructured":"23. YueXiao, GongXiang, TengFei, et al. Epidemiologic features of genital <i>Chlamydia trachomatis<\/i> infection in national sexually transmitted disease surveillance sites in China from 2008 to 2015. Chin J Dermatol. 2016;49: 308-13."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lanjouw E, Ouburg S, de Vries H, et al. 2015 European guideline on the management of <i>Chlamydia trachomatis<\/i> infections. Int J STD AIDS. 2016; 27: 333-48.","DOI":"10.1177\/0956462415618837"},{"key":"25","unstructured":"25. Yue XL, Gong XD, Li J, et al, Epidemiologic features of genital <i>Chlamydia trachomatis<\/i> infection at national sexually transmitted disease surveillance sites in China, 2015-2019. Chin J Dermatol. 2020; 53: 596-601."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Jeffrey F, Peipert. Genital chlamydial infections. N Engl J Med. 2003; 349:2424-30.","DOI":"10.1056\/NEJMcp030542"},{"key":"27","unstructured":"27. Health and Family Planning Commission of Shandong Province. 2017 Shandong province health and family planning development statistics bulletin. Available at &lt;http:\/\/wsjkw.shandong.gov.cn&gt;. Accessed May 10 2021."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Chernesky MA, The laboratory diagnosis of <i>Chlamydia trachomatis<\/i> infections. Can J Infect Dis Med Microbiol. 2005;16: 39-44.","DOI":"10.1155\/2005\/359046"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Jaton K, Bille J, Greub G, et al. A novel real-time PCR to detect <i>Chlamydia trachomatis<\/i> in first-void urine or genital swabs. J Med Microbiol. 2006; 55:1667-74.","DOI":"10.1099\/jmm.0.46675-0"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Gaydos CA, Van Der Pol B, Jett-Goheen M, et al. Performance of the cepheid CT\/NG Xpert rapid PCR test for detection of <i>Chlamydia trachomatis<\/i> and neisseria gonorrhoeae; J Clin Microbiol. 2013; 51:1666-72.","DOI":"10.1128\/JCM.03461-12"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. LeFevre ML. Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 161: 902-10.","DOI":"10.7326\/M14-1981"},{"key":"32","unstructured":"32. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015; 64:1-137."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Mahony J, Chong S, Jang D, et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of <i>Chlamydia trachomatis<\/i> nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: Identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol. 1998; 36:3122-6.","DOI":"10.1128\/JCM.36.11.3122-3126.1998"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Yeung A, Temple-Smith M, Spark S, et al. Improving chlamydia knowledge should lead to increased chlamydia testing among Australian general practitioners: a cross-sectional study of chlamydia testing uptake in general practice. BMC Infect Dis. 2014; 14:584.","DOI":"10.1186\/s12879-014-0584-2"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Messacar K, Dominguez SR. Blood PCR testing for enteroviruses in young children. Lancet Infect Dis. 2018; 18: 1299-301.","DOI":"10.1016\/S1473-3099(18)30492-4"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Papazian L, Calfee CS, Chiumello D, et al. Diagnostic workup for ARDS patients. Intensive Care Med. 2016; 42: 674-85.","DOI":"10.1007\/s00134-016-4324-5"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Patel M. 16S rDNA PCR in diagnosis of Lemierre&apos;s syndrome. Lancet Infect Dis. 2013; 13: 197.","DOI":"10.1016\/S1473-3099(13)70029-X"},{"key":"38","unstructured":"38. Lawmakers. Measures for the prevention and control of STD. Available at &lt;http:\/\/www.nhc.gov.cn\/fzs\/s3576\/201808\/6d00c158844f42c5bcf94993bffa665a.shtml&gt;. Accessed May 11 2021. Chinese."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Lewis Joanna, White Peter J. Changes in chlamydia prevalence and duration of infection estimated from testing and diagnosis rates in England: a model-based analysis using surveillance data, 2000-15. Lancet Public Health. 2018; 3: e271-8.","DOI":"10.1016\/S2468-2667(18)30071-9"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/74\/3\/74_JJID.2020.504\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T05:36:26Z","timestamp":1623303386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/74\/3\/74_JJID.2020.504\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,31]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2020.504","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,31]]}}}